Royal Bank of Canada’s Compugen CGEN Stock Holding History

Royal Bank of Canada’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-33,200	Closed	-$49K	–	7207
2025 Q3	$49K	Buy	33,200 +18,600	+127%	+$27.6K	﹤0.01%	5826
2025 Q2	$26K	Buy	+14,600	New	+$21.6K	﹤0.01%	6174
2023 Q2	–	Sell	-18	Closed	–	–	7289
2023 Q1	$0	Hold	18	–	–	﹤0.01%	7103
2022 Q4	$0	Buy	18 +17	+1,700%	+$15	﹤0.01%	7267
2022 Q3	$0	Hold	1	–	–	﹤0.01%	7479
2022 Q2	$0	Sell	1 -13	-93%	-$28	﹤0.01%	7397
2022 Q1	$0	Sell	14 -114,472	-100%	-$387K	﹤0.01%	7762
2021 Q4	$493K	Sell	114,486 -8,653	-7%	-$46.8K	﹤0.01%	4464
2021 Q3	$735K	Sell	123,139 -97	-0.1%	-$650	﹤0.01%	3991
2021 Q2	$1.02M	Buy	123,236 +8,875	+8%	+$72.1K	﹤0.01%	3629
2021 Q1	$982K	Buy	114,361 +13,678	+14%	+$152K	﹤0.01%	3609
2020 Q4	$1.22M	Sell	100,683 -9,631	-9%	-$133K	﹤0.01%	3338
2020 Q3	$1.79M	Buy	110,314 +21,279	+24%	+$349K	﹤0.01%	2773
2020 Q2	$1.34M	Buy	89,035 +30,907	+53%	+$417K	﹤0.01%	2931
2020 Q1	$422K	Buy	58,128 +1,900	+3%	+$14.9K	﹤0.01%	3756
2019 Q4	$335K	Buy	56,228 +228	+0.4%	+$1.17K	﹤0.01%	4257
2019 Q3	$237K	Sell	56,000 -1,500	-3%	-$5.61K	﹤0.01%	4345
2019 Q2	$221K	Buy	57,500 +30,800	+115%	+$109K	﹤0.01%	4420
2019 Q1	$111K	Buy	26,700 +800	+3%	+$2.75K	﹤0.01%	4711
2018 Q4	$56K	Hold	25,900	–	–	﹤0.01%	5037
2018 Q3	$100K	Buy	25,900 +14,900	+135%	+$52.1K	﹤0.01%	4860
2018 Q2	$36K	Buy	11,000 +9,996	+996%	+$37.6K	﹤0.01%	5294
2018 Q1	$4K	Hold	1,004	–	–	﹤0.01%	5981
2017 Q4	$3K	Sell	1,004 -450	-31%	-$1.34K	﹤0.01%	6188
2017 Q3	$6K	Sell	1,454 -4,446	-75%	-$15.4K	﹤0.01%	6388
2017 Q2	$22K	Sell	5,900 -24,079	-80%	-$100K	﹤0.01%	5496
2017 Q1	$129K	Buy	29,979 +2,500	+9%	+$11.5K	﹤0.01%	4603
2016 Q4	$140K	Sell	27,479 -10,921	-28%	-$65.4K	﹤0.01%	4699
2016 Q3	$242K	Sell	38,400 -7,500	-16%	-$50.8K	﹤0.01%	4293
2016 Q2	$297K	Sell	45,900 -8,000	-15%	-$53.4K	﹤0.01%	4107
2016 Q1	$301K	Hold	53,900	–	–	﹤0.01%	4060
2015 Q4	$344K	Sell	53,900 -1,800	-3%	-$11.8K	﹤0.01%	4106
2015 Q3	$288K	Sell	55,700 -5,000	-8%	-$29.1K	﹤0.01%	4015
2015 Q2	$421K	Sell	60,700 -13,000	-18%	-$91K	﹤0.01%	3773
2015 Q1	$520K	Buy	73,700 +2,500	+4%	+$20.5K	﹤0.01%	3471
2014 Q4	$593K	Buy	71,200 +8,300	+13%	+$63.9K	﹤0.01%	3386
2014 Q3	$539K	Buy	62,900 +7,500	+14%	+$66.6K	﹤0.01%	3392
2014 Q2	$498K	Buy	55,400 +3,220	+6%	+$29K	﹤0.01%	3402
2014 Q1	$549K	Buy	52,180 +46,150	+765%	+$508K	﹤0.01%	3274
2013 Q4	$54K	Buy	6,030 +5,830	+2,915%	+$57K	﹤0.01%	4849
2013 Q3	$2K	Buy	+200	New	+$1.56K	﹤0.01%	5846

Other funds holding CGEN

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

YLHM

Yelin Lapidot Holdings Management Tel Aviv, Israel $480M AUM 42.17% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Royal Bank of Canada's CGEN Position: Q4 2025 in Review

Royal Bank of Canada sold out of Compugen (CGEN) in Q4 2025, closing a stake of 33,200 shares — an estimated $49K sold.

Royal Bank of Canada first reported a position in CGEN in Q3 2013 and held it in 41 quarters. The position peaked at $1.79M in Q3 2020. 72 funds tracked by Wall St. Rank hold CGEN as of Q4 2025.

Royal Bank of Canada reported no remaining Compugen position as of Q4 2025 after selling out during the quarter.
Royal Bank of Canada sold 33,200 Compugen shares in Q4 2025, an estimated $49K.
Royal Bank of Canada first reported a position in Compugen in Q3 2013 and held it in 41 quarters.
Royal Bank of Canada's Compugen position peaked at $1.79M in Q3 2020.
72 funds tracked by Wall St. Rank held Compugen as of Q4 2025.

Based on Royal Bank of Canada's 13F filing for Q4 2025, filed 17 Feb 2026.